Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy

Journal of Nuclear Medicine

Volumn 40, Issue 6, 1999, Pages 904-910

  Bengel, Frank M ^a,b   Barthel, Petra ^a   Matsunari, Ichiro ^a   Schmidt, Georg ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

123I metaiodobenzylguanidine; Heart rate variability; Myocardial infarction; Reperfusion therapy; Washout

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; THALLIUM 201; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG UPTAKE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPATHETIC TONE; BIOLOGICAL MODEL; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; HEART; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE; HEART RATE; LUNG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING; STATISTICAL ANALYSIS; TIME;

3-IODOBENZYLGUANIDINE; AGED; ARRHYTHMIA; DATA INTERPRETATION, STATISTICAL; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROPHYSIOLOGY; FEMALE; HEART; HEART RATE; HUMANS; IODINE RADIOISOTOPES; LUNG; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TIME FACTORS;

EID: 0032587184     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hartikainen J, Kuikka J, Mantysaari M, Lansimies E, Pyorala K. Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol 1996;77:5-9.
2. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol. 1991;17:1416-1423.
3. Mantysaari M. Kuikka J, Hartikainen J, et al. Myocardial sympathetic nervous dysfunction detected with iodine-123-MIBG is associated with low heart rate variability after myocardial infarction. J Nucl Med. 1995;36:956-961.
4. Minardo JD, Tuli MM, Mock BH, et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation. 1988;78:1008-1019.
5. McGhie Al, Corbett JR, Akers MS, et al. Regional cardiac adrenergic function using I-123 meta-iodohenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol. 1991;67:236-242.
6. Newman D, Munoz L, Chin M, et al. Effects of canine myocardial infarction on sympathetic efferent neuronal function: scintigraphic and electrophysiologic correlates. Am Heart J. 1993;126:1106-1112.
7. Spinnler MT, Lomhardi F, Moretti C, et al. Evidence of functional alterations in sympathetic activity after myocardial infarction. Eur Heart J. 1993;14:1334-1343.
8. Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol. 1989;14:1519-1526.
9. Fagret D, Wolf JE, Vanzetto G. Borrel E. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med. 1993;34:57-60.
10. Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988;78: 1192-1199.
11. Imamura Y, Ando H, Mitsuoka W, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995;26:1594-1599.
12. Morimoto S, Terada K, Keira N, et al. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging. Eur J Nucl Med. 1996;23:756-761.
13. 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun. 1994;15:317-323.
14. Kurata C, Shouda S, Mikami T, et al. Comparison of I-123 metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine levels. J Nucl Cardiol. 1997;4:515-523.
15. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334:1084-1089.
16. Carrio I, Estorch M, Berna L, Lopez PJ, Tabernero J, Torres G. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity. J Nucl Med. 1995;36:2044-2049.
17. Fukuoka S, Hayashida K, Hirose Y. et al. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy. Eur J Nucl Med. 1997;24:523-529.
18. Wieland DM, Brown LE, Rogers WL, et al. Myocardial imaging with a radioiodinated norepinephnne storage analog. J Nucl Med. 1981;22:22-31.
19. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function. Eur J Nucl Med 1988;13:543-547.
20. Tobes MC, Jacques SJ, Wieland DM, Sisson JC. Effect of uptake-1 inhibitor on the uptake of norepinephrine and metaiodobenzylguanidine. J Nuclo Med 1985;26: 897-907.
21. Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra-and extravesicular accumulation in the rat heart. J Nucl Med. 1986;27:84-89.
22. Dae MW, De MT, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med. 1992;33:1444-1450.
23. Wakasugi S, Inoue M, Tazawa S. Assessment of adrenergic neuron function altered with progression of heart failure. J Nucl Med. 1995;36:2069-2074.
24. Glowniak JV. Cardiac studies with metaiodobenzylguanidine: a critique of methods and interpretation of results. J Nucl Med 1995;36:2133-2137.
25. Matsunari I, Barthel P, Bengel F, et al. Incidence and extent of denervated myocardium after reperfusion therapy for acute myocardial infarction assessed by I-123-metaiodobenzylguanidine imaging [abstract]. J Am Coll Cardiol. 1997;29: 342A.
26. Livanis EO, Flevari PG, Theodorakis GN, Vassilopoulos NG, Kremastinos DT. Decreased post-myocardial infarction heart rate variability and cardiac denervation assessed by metaiodobenzylguanidine scintigraphy. Am J Cardiol. 1997;79:482-486.
27. Bonaduce D, Marciano F, Petretta M, et al. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation. 1994;90:108-113.
28. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
29. Zuanetti G, Neilson JM, Latini R, Santoro E, Maggioni AP, Ewing DJ. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravivenza nell' Infarto Miocardico. Circulation. 1996;94:432-436.